Definium Therapeutics (DFTX) Cash from Operations Growth (1y) (2022 - 2026)
Definium Therapeutics (DFTX) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Definium Therapeutics |
2.46 Bn |
2.09 Bn |
- |
-44.91% |
| Date | Value |
|---|
| Mar 31, 2026 |
-44.91% |
| Dec 31, 2025 |
-69.52% |
| Sep 30, 2025 |
-71.99% |
| Jun 30, 2025 |
-48.08% |
| Mar 31, 2025 |
-77.24% |
| Dec 31, 2024 |
-23.28% |
| Sep 30, 2024 |
-3.40% |
| Jun 30, 2024 |
-44.38% |
| Mar 31, 2024 |
-24.51% |
| Dec 31, 2023 |
-60.04% |
| Sep 30, 2023 |
-78.83% |
| Jun 30, 2023 |
8.47% |
| Mar 31, 2023 |
-3.61% |
| Dec 31, 2022 |
-64.04% |
| Sep 30, 2022 |
44.60% |
| Jun 30, 2022 |
-35.41% |
| Mar 31, 2022 |
-28.17% |
